Jianfeng Xu
- Molecular Biology top 0.5%
- Pulmonary and Respiratory Medicine top 0.1%
- Oncology top 0.2%
- Cancer Research top 0.1%
- Genetics top 0.2%
- Co-authors
- Ahmedin JemalM. J. ThunRebecca L. SiegelYongping HaoElizabeth WardTaylor MurrayElizabeth M. WardWilliam B. Isaacs
- Topics
- Prostate Cancer Treatment and Research (73 papers)Genetic Associations and Epidemiology (49 papers)Prostate Cancer Diagnosis and Treatment (28 papers)
- Partner nations
- United StatesChinaSweden
In The Last Decade
Jianfeng Xu
324 papers receiving 26.1k citations
Hit Papers
Peers
Comparison fields: 5 of 188
- Molecular Biology 9.3k
- Pulmonary and Respiratory Medicine 7.6k
- Oncology 6.9k
- Cancer Research 4.9k
- Genetics 3.8k
Countries citing papers authored by Jianfeng Xu
This map shows the geographic impact of Jianfeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianfeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianfeng Xu more than expected).
Fields of papers citing papers by Jianfeng Xu
This network shows the impact of papers produced by Jianfeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianfeng Xu. The network helps show where Jianfeng Xu may publish in the future.
Co-authorship network of co-authors of Jianfeng Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Jianfeng Xu. A scholar is included among the top collaborators of Jianfeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianfeng Xu. Jianfeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 0 | |
| 5 | 4 | |
| 6 | 18 | |
| 7 | 2 | |
| 8 | 23 | |
| 9 | 38 | |
| 10 | 14 | |
| 11 | Epidemiologic Association of Nonalcoholic Fatty Liver Disease and Urinary Calculi: a Population-based Cross-sectional Study in Southern China. | 15 |
| 12 | 45 | |
| 13 | 55 | |
| 14 | 7 | |
| 15 | 262 | |
| 16 | 14 | |
| 17 | 45 | |
| 18 | 36 | |
| 19 | 58 | |
| 20 | 79 |
About Jianfeng Xu
Jianfeng Xu is a scholar working on Cancer Research, Genetics and Pulmonary and Respiratory Medicine, having authored 344 papers that have together received 26.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (73 papers), Genetic Associations and Epidemiology (49 papers) and Prostate Cancer Diagnosis and Treatment (28 papers). The work is most often cited by research in Cancer Research (4.9k citations), Oncology (6.9k citations) and Pulmonary and Respiratory Medicine (7.6k citations). Jianfeng Xu has collaborated with scholars based in United States, China and Sweden. Frequent co-authors include Ahmedin Jemal, M. J. Thun, Rebecca L. Siegel, Yongping Hao, Elizabeth Ward, Taylor Murray, Elizabeth M. Ward, William B. Isaacs, Deborah A. Meyers and Henrik Grönberg. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.